EBI-1051

• UNSPSC Description:

  EBI-1051 is a highly potent and orally efficacious MEK inhibitor with an IC50 of 3.9 nM.

• Target Antigen:

  MEK

• Type:

  Reference compound

• Related Pathways:

  MAPK/ERK Pathway

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/EBI-1051.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(NOC(CO)CO)C1=C(NC2=CC=C(I)C=C2F)C(F)=C3C(C=CO3)=C1

• Molecular Weight:

  504.22

• References & Citations:

  [1]Lu B, et al. Discovery of EBI-1051: A novel and orally efficacious MEK inhibitor with benzofuran scaffold. Bioorg Med Chem. 2018 Feb 1;26(3):581-589.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1801896-05-8